Health Care Reform

Our guest on this episode, former professional poker player turned benefits advisor John Sbrocco, has spent time, money and a whole lot of effort to be that advisor, and in the 2-part interview, he shares what he has learned.

Insys Therapeutics could become the first corporate casualty of the opioid epidemic, collapsing under legal expenses and plummeting sales.

Take a look at several converging market dynamics that are purported to bring about great change to the pharma industry in 2019.

Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry.

We cast a net far and wide, soliciting our readers’ input on significant events and trends for 2019. Here are the highlights.

An email campaign from the CMS appears to be encouraging enrollees to opt for private Medicare Advantage plan instead of original Medicare.